Inspection·July 1, 2025

F 0760 Ensure that residents are free from significant medication errors. Level of Harm - Minimal harm or potential for actual harm **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on review of facility policy, clinical record review, review of facility provided documentation and staff interview, it was determined that the facility failed to make certain that residents are free of significant medication errors for two of four residents (Residents R1 and R2). Residents Affected - Some Findings include: Review of facility policy Medication Administration dated 4/30/25, indicated that medications will be administered in accordance with prescriber orders, including any required timeframe. Staffing Schedules are arranged to ensure that medications are administered without unnecessary interruptions. medications are administered within one hour of their prescribed time unless otherwise specified(before and after meals). The facility meal times posted indicated 7:15 a.m., 12:00 p.m., and 5:00 p.m. Review of the National Library of Medicine information, indicated insulin Lantus(glargine) is an injectable medication used to treat diabetes (a metabolic disorder in which the body has high sugar levels for prolonged periods of time). It further stated, Lantus can cause side effects , including low blood sugar (hypoglycemia). Review of the National Library of Medicine information, indicated insulin Lispro as a fast acting injectable medication use to treat diabetes. It further stated Lispro insulin begins to exert its effects within 15 minutes and should be 30 to 45 minutes before meals. Review of the clinical record indicated Resident R1 was admitted to the facility on [DATE], with diagnosis of diabetes. Review of the physician orders May 2025, indicated to give Resident R1 insulin Lantus(glargine) 7 units inject subcutaneously every day, timed at 9:00 a.m. Review of the Medication Administration Record(MAR) indicated Resident R1 was given Lantus insulin as follows: 5/10/25, at 12:21 p.m. 5/18/25 at 1:04 p.m. 5/31/25 at 1:34 p.m. 5/16/25, at 1:46 p.m. 5/21/25 at 1:14 p.m. 5/17/25, at 12:19 p.m. 5/30/25 at 12:53 p.m. (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 3 Event ID: 395013 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 395013 B. Wing A. Building (X3) DATE SURVEY COMPLETED 07/01/2025 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Eldercrest Rehabilitation & Healthcare Center 2600 West Run Road Munhall, PA 15120 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)